• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CBER advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of June 30, 2014.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 2012106
Nov 2012106
Dec 2012106
Jan 2013107
Feb 2013108
Mar 2013108
Apr 2013108
May 20131010
Jun 2013104
Jul 2013100
Aug 2013100
Sep 2013100

Number of CBER advisory committee member positions vacant at the end of the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2012N/A4
Nov 2012N/A4
Dec 2012N/A4
Jan 2013N/A5
Feb 2013N/A6
Mar 2013N/A6
Apr 2013N/A6
May 2013N/A7
Jun 2013N/A3
Jul 2013N/A0
Aug 2013N/A0
Sep 2013N/A0

Total number of CBER advisory committee member positions at the end of the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2012N/A71
Nov 2012N/A71
Dec 2012N/A71
Jan 2013N/A71
Feb 2013N/A71
Mar 2013N/A71
Apr 2013N/A71
May 2013N/A71
Jun 2013N/A71
Jul 2013N/A71
Aug 2013N/A71
Sep 2013N/A71
Oct 2013N/A71
Nov 2013N/A71
Dec 2013N/A71
Jan 2014N/A71
Feb 2014N/A71
Mar 2014N/A71
Apr 2014N/A71
May 2014N/A71
Jun 2014N/A71
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.